Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
N-Allylcyclohexylamine → N-Allyl-N-cyclohexyl-2-[4-(3,3-diphenyl-1-propyl)piperazin-1-yl]-5-methylisonicotinamide
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | N-Allylcyclohexylamine | HCID 81115 | — |
| 반응물 | 2-[4-(3,3-Diphenyl-1-propyl)piperazin-1-yl]-5-methylisonicotinic acid | HCID 22180640 | — |
| 생성물 | N-Allyl-N-cyclohexyl-2-[4-(3,3-diphenyl-1-propyl)piperazin-1-yl]-5-methylisonicotinamide | HCID 22180511 | 72.8% |
반응 단계
Step (d) of Example 107 was repeated, except that the compound (50 mg) prepared in step (d) of Example 108 and allylcyclohexylamine (34 mg) were used as the starting compounds. Thus, the title compound (47 mg) was obtained.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07030120B2 |
| 출처 데이터셋 | uspto-grants-2006_04 |
| ORD ID | ord-8e757de0a427484089bebbeffbfb2f9f |
| 출처 메모 | uspto-grants-2006_04 |